Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
San'ao Tang is a classic Traditional Chinese Medicine (TCM) formula originating from the *Taiping Huimin Heji Jufang*. It typically consists of three primary herbal ingredients: *Ephedra sinica* (Ma Huang), *Prunus armeniaca* (Xing Ren), and *Glycyrrhiza uralensis* (Gan Cao). Traditionally used to treat respiratory conditions characterized by "external wind-cold" and "lung qi obstruction," such as the common cold, cough, and asthma, it is currently being evaluated in clinical trials for refractory chronic cough. The formula is often administered as granules or a decoction and is sometimes combined with other TCM formulations like Qingjin Huatan Tang to address complex syndromes involving both cold and heat. Its pharmacological effects include bronchodilation, anti-inflammatory activity, and regulation of airway hyperresponsiveness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on San'ao Tang.